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Abstract
Atypical Chemokine Receptor 1 (ACKR1), previously known as the Duffy Antigen Receptor for 
Chemokines, stands out among chemokine receptors for its high selective expression on Purkinje 
cells of the cerebellum, consistent with the ability of ACKR1 ligands to activate Purkinje cells in 
vitro. Nevertheless, evidence for ACKR1 regulation of brain function in vivo has been lacking. 
Here we demonstrate that Ackr1−/− mice have markedly impaired balance and ataxia when placed 
on a rotating rod and increased tremor when injected with harmaline, a drug that induces whole-
body tremor by activating Purkinje cells. Ackr1−/− mice also exhibited impaired exploratory 
behavior, increased anxiety-like behavior and frequent episodes of marked hypoactivity under 
low-stress conditions. The behavioral phenotype of Ackr1−/− mice was the opposite of the 
phenotype occurring in mice with cerebellar degeneration and the defects persisted when Ackr1 
was deficient only on non-hematopoietic cells. We conclude that normal motor function and 
behavior depend in part on negative regulation of Purkinje cell activity by Ackr1.
INTRODUCTION
Atypical Chemokine Receptor 1 (ACKR1) is a new standardized name for the Duffy 
Antigen Receptor for Chemokines (DARC). A member of the 7-transmembrane (7TM) 
domain protein superfamily, ACKR1 is able to bind specifically to many pro-inflammatory 
chemokines; however, unlike typical 7TM proteins (but like other ACKRs), it is unable to 
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signal through heterotrimeric G proteins (1–4). Some ACKRs have been shown to signal 
through arrestin-dependent pathways, but so far evidence of this is lacking for ACKR1 (5).
Another unusual feature of ACKR1 is that, unlike other chemokine receptors, including 
other ACKRs, ACKR1 does not appear to be expressed on leukocytes; instead, it is 
expressed by erythrocytes, endothelial cells of post-capillary venules, and in the brain. On 
erythrocytes it was first identified as the Duffy Antigen, a polymorphic determinant of 
ACKR1 that defines the Fy blood group system (6, 7). Erythrocyte ACKR1 is thought to 
scavenge chemokines, to both shape and buffer chemokine concentration gradients during 
inflammatory responses (8, 9). In addition, in humans, erythrocyte ACKR1 is exploited for 
cell entry by Plasmodium vivax, a major cause of malaria, and red blood cell selective 
ACKR1-negative individuals with a mutation in the ACKR1 promoter are protected from 
this disease (10, 11). On endothelial cells (12), ACKR1 is thought to mediate transcytosis of 
chemokines for subsequent presentation to blood leukocytes (13).
In human brain, ACKR1 is expressed specifically on cerebellar Purkinje neurons as 
demonstrated by immunohistochemistry (14, 15). Likewise, in mouse brain, in situ 
hybridization data from the Allen brain atlas (16) and published PCR data (17) show that 
Ackr1 is expressed at highest levels in the cerebellum, and less so in other brain regions like 
olfactory bulb, parts of the cortex and hypothalamus (16). Consistent with the expression 
data, Ackr1-binding chemokines have been reported to activate Purkinje cells in vitro. In 
particular, CCL2 induces Ca2+ flux in rat Purkinje neurons (18), and CXCL1 and CXCL8 
induce Ca2+ transients in mouse cerebellar slices (19). CXCL2, which also binds to Ackr1 
(20, 21), seems to modulate neurotransmitter release in rat cerebellum by activating ERK in 
cerebellar granule cells (22). In addition, rat Purkinje neurons respond to the chemokines 
CCL2, CCL5 and CCL11 (23), all of which also bind to ACKR1 with high affinity (4). A 
reasonable hypothesis is that these responses are mediated by cognate G protein-coupled 
chemokine receptors, but negatively regulated by ACKR1 through its known scavenging 
function.
Despite these advances, evidence for an actual biological role for ACKR1 in brain in vivo 
has been lacking since its brain expression was discovered in 1994. Ackr1 −/− mice were 
tested in several behavioral paradigms and reported to show normal performance (24). In 
rare cases ACKR1 is also silenced in humans in all tissues, including brain, due to a 
premature stop codon in the ACKR1 open reading frame. No behavioral abnormalities, 
however, were described for these persons (25). Since such patients are rare, however, it is 
difficult to examine them systematically for neurologic and behavioral abnormalities, and 
the knockout mouse behavioral analysis was limited in scope. Therefore, we decided to re-
investigate whether ACKR1 regulates central nervous system function in mice, using motor 
challenges (rotarod and Morris water maze) or experimental paradigms for the determination 
of gait, tremor and anxiety-like- or exploratory behavior (force plate actometer, elevated 
plus maze).
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Ackr1 deficiency impairs balance and motor behavior on the rotarod
In rotarod experiments, the animal is subjected to a vestibulomotor challenge by being 
placed on a rotating cylinder suspended above a platform. Since deficits in motor 
coordination or balance, e. g. caused by defects in cerebellar function, result in impaired 
performance in this test (26–28), and since Ackr1 is highly expressed in cerebellum, we 
hypothesized that rotarod performance would be impaired in Ackr1-deficient mice.
Consistent with this, in four independent experiments with non-littermates (three trials per 
mouse and different mice in each experiment), Ackr1−/− mice fell off the rotarod 30–40% 
sooner than Ackr1+/+ control mice that had been used for backcrossing (Figure 1A and B; 
p<0.001). To exclude effects by background mutations in other genes, we repeated the 
experiments with littermates of Ackr1+/− X Ackr1+/− crosses in six independent experiments 
with six trials per mouse and experiment (two days with three trials per mouse). In each 
experiment, different mice were used. Analysis of all data for all animals demonstrated that 
rotarod performance was significantly impaired in Ackr1−/− mice on day 1 and in both 
Ackr1+/− and Ackr1−/− mice on day 2 (Figure 1C), pointing strongly to Ackr1 as the gene 
responsible for this phenotype. This appeared to be related to a slower rate of improvement 
with repeated trials of Ackr1−/− mice compared to Ackr1+/+ mice, which was particularly 
evident in trials 4 and 5 on day 2 (Figure 1D). Video analysis showed that Ackr1−/− mice 
exhibited evidence of mild ataxia while on the rotarod (Suppl. movies 1 and 2). In particular, 
the Ackr1−/− mouse is slower in stepping forward and the hind feet are carried lower relative 
to the rod axis, eventually losing their grip. Mice normally make occasional 180° turns 
relative to the vertical axis, which requires complex motor coordination. Table 1 shows a 
trend towards a reduced number of 180° turns in Ackr1+/−- and Ackr1−/− mice as compared 
to Ackr1+/+ controls. Since the data were not normally distributed, we performed a 
nonparametric Kruskal-Wallis analysis, yielding a genotype effect close to significance for 
day 1 (p = 0.0594). A post-hoc nonparametric Mann-Whitney U test yielded a significant 
difference between Ackr1+/+ and Ackr1+/− mice on day 1 of the rotarod experiment (p = 
0.0237). This result additionally points to impaired motor coordination of Ackr1−/− mice.
Ackr1-deficiency reduces locomotion and promotes anxiety-like behavior on the elevated 
plus maze
The cerebellum may be involved not only in balance but also in emotional processes and 
anxiety (29, 30). Therefore, we next tested the performance of Ackr1-deficient mice on an 
elevated plus maze, an apparatus designed to make mice choose between either avoiding a 
potentially harmful situation that induces anxiety or engaging their natural curiosity in 
explorative behavior. The apparatus consists of two narrow platforms mounted ~60 cm 
above the floor that intersect perpendicularly at their centers, forming a plus sign. Both arms 
of one platform have walls (the ‘closed’ arms or ‘safe’ space), whereas both arms of the 
other platform lack walls (the ‘open’ arms or ‘risky’ space). The animals are initially placed 
undisturbed in the center, and their movements are tracked (Figure 2A).
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Compared to Ackr1+/+ mice, the total number of arm entries from the center was 
significantly lower for both Ackr1+/− and Ackr1−/− mice (Figure 2B). This was associated 
with reduced average running speed and reduced percentage of open arm entries for 
Ackr1+/− mice, as well as significantly less time spent in the center for Ackr1+/− and 
Ackr1−/− mice (Figure 2C–E). The strongest effect of Ackr1 deficiency, however, was only 
apparent when full length open arm exploration was analyzed. Unlike wild type mice, both 
Ackr1−/− and Ackr1+/− mice rarely explored the full length of the open arms (Suppl. Figure 
1). To quantitate this phenotype, we calculated the time spent beyond the midpoint of the 
open arms, highlighted in red in Figure 2A. Both Ackr1+/− and Ackr1−/− mice spent 
significantly less time in the outer half of the open arms than Ackr1+/+ controls, consistent 
with heightened anxiety (Figure 2F).
Ackr1-deficiency reduces spontaneous locomotion but induces spontaneous anxiety like-
behavior and worsens harmaline-induced cerebellar tremor
We next studied behavior under virtually unstressed conditions, where the mouse can freely 
explore its environment. We used a force plate actometer, a square platform mounted on 
highly sensitive force transducers capable of detecting force across the platform surface with 
a time resolution as high as 0.01 s. Male and female Ackr1−/−, Ackr1+/− and Ackr1+/+ 
littermates were monitored in 30 min sessions. Neither the force exerted on the plate during 
running sequences nor the gait frequency was significantly different in Ackr1+/− or Ackr1−/− 
mice compared to Ackr1+/+ controls (Figure 3A and B). In contrast, wall rear duration was 
prolonged in both Ackr1+/− and Ackr1−/− mice (Figure 3C). Ackr1 deficiency was also 
associated with a significantly reduced percentage of total time spent in the platform center, 
an indicator of increased anxiety consistent with the elevated plus maze results (Figure 3D).
The actometer also revealed markedly reduced spontaneous locomotor activity in both 
Ackr1+/− (p = 0.002) and Ackr1−/− mice (p = 0.005) (Figure 3E). The difference was 
apparent at the start of the session and persisted throughout. Nevertheless, wild-type controls 
appeared to ‘settle down’ more than knockouts during the first 3 minutes, probably because 
they started at a much higher activity level. The Ackr1-dependent reduction in spontaneous 
activity was caused mainly by a markedly increased frequency of hypoactive events, defined 
as movement limited to a radius <15mm for at least 5s (Figure 3F, Suppl. videos 3 and 4).
To determine whether Ackr1 might regulate Purkinje neuron function in vivo, we injected 
mice with 15 mg/kg of harmaline, a drug that specifically stimulates Purkinje neurons and 
deep cerebellar nuclei via excitation of climbing fibers originating from the inferior olivary 
nucleus. This results in whole-body tremor, and is used as a model of essential tremor (31). 
Actometer recordings indicated that Ackr1-deficient mice had increased harmaline tremor 
intensity (Figure 3G) and frequency (Figure 3H), suggesting that Ackr1 modulates Purkinje 
neuron function in vivo.
Ackr1 deficiency does not affect acquisition learning and visual acuity in the Morris water 
maze apparatus
We next evaluated Ackr1-deficient mice in the Morris water maze apparatus, which tests 
learning, memory and spatial orientation, involving several brain regions, including 
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hippocampus and cerebellum (28, 32, 33). The animal is tasked to swim until it finds a 
submerged, invisible platform; safe harbor provides positive reinforcement promoting 
learning and memory (34). This test was most useful for establishing that Ackr1 deficiency 
did not affect visual acuity, which can affect outcome from most behavioral tests, 
specifically from elevated plus maze, rotarod and the Morris water maze test itself. In 
particular, all mice were able to see the platform when it was elevated above the water 
surface in the center of the pool. Under these conditions all mice found the platform within a 
time span that was comparable with the swimming time on the last day of the acquisition 
learning phase (data not shown).
Figure 4 summarizes results of three independent water maze experiments. There is high 
inter-experimental variability for most parameters, so the results of each experiment are also 
shown in Suppl. Figure 2. The results for the distance swum to reach the platform were the 
most consistent. In particular, although no differences between Ackr1−/− and Ackr1+/+ mice 
were observed for this parameter during the acquisition phase in any of the three 
experiments (Figure 4C, left part; Suppl. Figure 2C, G, K, left part), during reversal 
learning, Ackr1−/− mice showed reduced swimming distance compared to Ackr1+/+ controls 
in all three experiments (Figure 4C, right part; p = 0.023; Suppl. Figure 2C, G, K, right part). 
Increased thigmotaxis behavior (tendency to swim near the wall of the tank, a measure of 
anxiety) was observed in Ackr1−/− mice in the reversal learning phase of experiments 1 and 
2, but not experiment 3 (Suppl. Figure 2D, H, L) . This reached statistical significance for 
the summarized data as shown in Figure 4D (right part; p = 0.04). Differences in swimming 
speed and latency to find the platform were only found in experiment 1 (Suppl. Figure 2). 
Learning the platform location was also tested in probe trials with the platform removed. 
Except for the first water maze experiment, where acquisition learning was impaired in 
Ackr1−/− mice, all mice clearly preferred the quadrant where the platform had been located 
before (data not shown).
Behavior is regulated mainly by Ackr1 on non-hematopoietic cells
To determine whether hematopoietic or non-hematopoietic Ackr1, or both, regulate 
behavior, we generated radiation bone marrow chimeras. Six weeks after transplantation in 
both sexes, engraftment was ~100% when Ackr1−/− bone marrow was transferred into 
irradiated Ackr1+/+ recipients (Ackr1−/−➔Ackr1+/+), and at least 80 % for the converse 
transfer (Ackr1+/+ ➔ Ackr1−/−) (Figure 5).
Consistent with the results shown in Figure 1 for non-chimeric Ackr1+/+ and Ackr1−/− mice, 
matched chimeras made by transferring Ackr1−/− donor bone marrow to irradiated Ackr1−/− 
recipients (Ackr1−/−➔Ackr1−/−) fell off the rotarod much sooner than Ackr1+/+➔Ackr1+/+ 
chimeras (Figure 6). Genotype-mismatched Ackr1+/+➔Ackr1−/− chimeras performed as 
poorly as Ackr1−/− ➔Ackr1−/− controls, whereas the reciprocally mismatched 
Ackr1−/−➔Ackr1+/+ chimeras performed as well as Ackr1+/+➔Ackr1+/+ controls. Thus, 
impaired rotarod performance depends on Ackr1 deficiency on non-hematopoietic cells, not 
hematopoietic cells, consistent with effects of Ackr1 in irradiation-resistant brain cells 
(Figure 6).
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A dependence of effects of Ackr1 on non-hematopoietic cells was also seen in three of the 
four parameters measured on the elevated plus maze (i.e., average running speed, total 
number of arm entries, and duration in the center) (Figure 7). The fourth parameter, 
percentage of open arm entries, was reduced in all chimeras tested as compared to 
corresponding non-chimeric littermates (compare Figures 2E and 7D, and Suppl. Figure 3), 
and no significant difference was detected between any of the groups. Unlike Ackr1+/+ mice 
(Suppl. Figure 1), the majority of chimeric mice made from Ackr1+/+ recipients, regardless 
of the donor bone marrow genotype, did not cross the midline of the open arm, indicating a 
generally increased state of anxiety, possibly attributable to irradiation (35), making this 
assay non-informative for this parameter.
In actometer experiments, we observed similar differences in behavior between 
Ackr1−/−➔Ackr1−/− and Ackr1+/+➔Ackr1+/+ chimeras as we had observed between non-
chimeric Ackr1+/+ and Ackr1−/− controls for all six unchallenged behavioral parameters 
measured (compare Figure 3A–F with Figure 8A–F). For two of these (i.e., force range 
within run and wall rear duration), performance was the same or very similar between 
Ackr1−/−➔Ackr1−/− and Ackr1+/+➔Ackr1+/+ chimeras (Figure 8A, C). Not surprisingly then, 
genotype-mismatched Ackr1+/+➔Ackr1−/− and Ackr1−/−➔Ackr1+/+ chimeras performed 
similarly in these two parameters to each other and to both matched chimera controls 
(Figure 8A, C). A relatively large difference in behavior was observed between 
Ackr1−/−➔Ackr1−/− and Ackr1+/+➔Ackr1+/+ chimeras as measured by the other four 
unchallenged parameters (gait rhythm, % of time spent in center, distance moved, and 
hypoactive events) (Figure 8 B, D–F). Like the rotarod and elevated plus maze tests, 
Ackr1+/+➔Ackr1−/− chimeras tended to perform most like Ackr1−/− ➔Ackr1−/− controls, 
whereas the reciprocally mismatched Ackr1−/−➔Ackr1+/+ chimeras performed most like 
Ackr1+/+➔Ackr1+/+ controls (Figure 8 B, D–F), suggesting that non-hematopoietic Ackr1 is 
important in regulating these behaviors, whereas hematopoietic Ackr1 is not.
With regard to the two parameters measured on the actometer after harmaline challenge, the 
intensity and frequency of harmaline-induced tremor, irradiation and bone marrow transfer 
attenuated both in chimeric mice compared to non-chimeric control mice (compare Figure 
3G–H with Figure 8G–H). Nevertheless, tremor intensity was still significantly increased in 
Ackr1−/−➔Ackr1−/− chimeras compared to Ackr1+/+➔Ackr1+/+ chimeras, phenocopying 
non-chimeric control mice (Figure 8G). Ackr1+/+➔Ackr1−/− and Ackr1−/−➔Ackr1+/+ 
genotype-mismatched chimeras both had a low tremor phenotype similar to 
Ackr1+/+➔Ackr1+/+ chimeras, suggesting that both hematopoietic and non-hematopoietic 
Ackr1may contribute to this phenotype (Figure 8G).
Ackr1 deficiency does not affect macroscopic brain anatomy
The brain of the Ackr1 knockout mouse has been reported to be macroscopically normal and 
there were no histological differences detected (24). However, since behavioral phenotypes 
had not previously been identified in this mouse, we decided to revisit this question. Using 
magnetic resonance imaging with brains from non-littermate Ackr1+/+- and Ackr1−/− mice, 
we observed no difference in cerebellar size between Ackr1+/+ and Ackr1−/− mice, 
confirming the previous report (24) (Suppl. Figure 4 A, B). A comparison of individual 
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brain slices across the entire brain also found no difference, except in the dorsal part, where 
Ackr1−/− brain appeared slightly smaller (Suppl. Figure 4C). However, we cannot exclude 
the possibility that this may be caused by respiration-induced motion artifacts in this region, 
which contains the brain stem.
DISCUSSION
In this study, we report the first evidence that the atypical chemokine receptor Ackr1 
regulates central nervous system function in vivo. Combined results from genetic, 
immunologic and pharmacologic analysis using Ackr1−/− mice, radiation chimeric mice, and 
the tremor-inducing drug harmaline all point to the cerebellum, and in particular Purkinje 
cells, as the key site of Ackr1 action in vivo. This is consistent with previously published 
results demonstrating selective very high expression of Ackr1 in cerebellum, specifically on 
Purkinje cells (14–16), which are known to respond to Ackr1 ligands in vitro (4, 18, 19).
Our results disagree with Luo et al, who had previously reported that Ackr1 deficiency did 
not affect performance in 15 different behavior paradigms, including two that we used 
(water maze and rotarod) (24). This group used an independently derived line of Ackr1−/− 
mice to obtain these negative results, and did not specify the experimental conditions, which 
could have differed substantially from ours and affected the outcome. Moreover, we used 
two additional tests, including ‘time spent in the terminal half of the opens arms’ on the 
elevated plus maze test, which is a highly sensitive measure of anxiety-like behavior, and 
the actometer, which allows highly sensitive digital analysis of mouse motion. Finally, we 
verified the phenotypes we discovered using three complementary types of mouse breeding 
paradigms (backcrossed, littermates and radiation chimeras).
Of the eighteen parameters measured across the four types of apparatus used in our study 
(one for the rotarod, five for the elevated plus maze, four for the Morris water maze and 
eight for the actometer), Ackr1−/− performance was abnormal (different from Ackr1+/+) in 
twelve. Four of the twelve were designed to measure anxiety-like behavior, although not 
specifically for the cerebellum, and the performances of the knockout mice were consistent 
with an increase in this behavioral state (restricted exploration of the terminal half of the 
open arms on the elevated plus maze, increased thigmotaxis in the Morris water maze, and 
decreased time spent in the center of the actometer and the elevated plus maze). The 
remaining eight parameters were used to measure locomotor activity and motor coordination 
in various ways, and the performances of the knockout mice were decreased in all eight. Of 
these eight, three (time on the rotarod, and harmaline-induced tremor intensity and 
frequency) are most clearly related to cerebellar function, where Ackr1 is highly expressed.
Impaired rotarod performance was unlikely to be caused by impaired vision, since visual 
testing of the knockouts in the Morris water maze was normal, or by impaired motor 
learning, since after the sixth rotarod session Ackr1−/− and Ackr1+/+ mouse performance was 
the same. Moreover, it is unlikely that muscle weakness was responsible for reduced rotarod 
performance in Ackr1-deficient animals, because Ackr1+/−- and Ackr1−/− mice did not show 
a significantly reduced force range within run as compared to Ackr1+/+ mice (Figure 3A). 
More likely contributing factors include ataxia, general hypoactivity, and increased anxiety. 
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Ataxia was directly observed on the rotarod rotarod, which represents a rather complex 
vestibulomotor challenge, whereas the virtually unchallenging actometer conditions revealed 
only a non-significant trend towards reduced gait frequency and running force. Hypoactivity 
was apparent in Ackr1−/− mice in five tests not specifically designed to interrogate 
cerebellar function, three on the actometer (wall rear duration, number of hypoactive events 
and distance moved) and two on the the elevated plus maze (running speed and total number 
of arm entries), and has previously been discussed as an explanation for poor rotarod 
performance by the R6/2 mouse model of Huntington’s disease (36). Increased wall rear 
duration may indicate impaired response termination, similar to results previously reported 
for D2R knockouts that show Parkinson-like symptoms (36, 37). However, wall rear 
duration is also used as a measure of non-selective attention in animal models of attention-
deficit hyperactivity disorder (38). Defects in both motor systems and cognitive functions 
could contribute to this phenotype.
The harmaline experiments provide the most direct in vivo evidence of Ackr1 action in the 
cerebellum. Harmaline is a β-carboline alkaloid that specifically stimulates rhythmic firing 
of neurons in the inferior olive (IO) of the brainstem. Each IO neuron projects onto a 
Purkinje cell via a “climbing fiber”. Purkinje neurons in turn connect to neurons of the deep 
cerebellar nuclei (DCN) that mediate cerebellar output. Some DCN neurons project back to 
the IO in an inhibitory way, resulting in a closed IO-, Purkinje- and DCN-neuron regulatory 
loop (39). The DCN represents the only output of the cerebellum and is indispensable for 
harmaline-induced tremor, projecting the harmaline-induced firing pattern from IO- to 
cerebellar Purkinje neurons (31). Mice with Purkinje cell degeneration (PCD mice) still 
express harmaline tremor, but with reduced intensity and frequency compared to wild-type 
controls (31, 40), suggesting that Purkinje neurons are not required for harmaline tremor 
(31), but modulate it. Our results obtained with Ackr1−/− mice suggest that Ackr1 on 
Purkinje neurons may alter tremor output from the DCN, probably by modulating Purkinje 
cell activity. Our results therefore point to an inhibitory effect of Ackr1 on the cerebellar 
output of harmaline-induced tremor, which will be discussed below.
The six parameters that were not clearly abnormal in Ackr1−/− mice include three on the 
water maze (latency and distance to find the platform, and swimming speed), and two on the 
actometer that were previously discussed (gait rhythm and force range within run). Due to 
poor reproducibility, the data from the water maze tests should be interpreted with caution. 
Ackr1−/− mice appeared to perform better than controls in the reversal learning paradigm, as 
indicated by decreased distance swum to find the platform in the reversal learning phase. 
Since acquisition learning was not influenced by Ackr1-deficiency, Ackr1 might affect 
behavioral flexibility and adaptation to new environmental conditions.
A weak gene dosage effect can be seen in the rotarod results (Figure 1) and in some of the 
actometer data (Figure 3A, D, H), resulting in an intermediate phenotype of Ackr1+/− mice 
as compared to Ackr1−/− animals and Ackr1+/+ controls. In most cases, however, the 
behavior of Ackr1+/− mice was similar to the behavior of full knockouts. Thus, maximum 
Ackr1 expression is required to reconstitute wild-type behavior.
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Bone marrow chimera experiments revealed that most behavioral phenotypes were fully 
determined by the Ackr1 genotype of the recipient mouse. Thus, we conclude that these 
phenotypes are due to Ackr1 deficiency on Purkinje cells and possibly neurons from other 
brain regions. A moderate effect of donor genotype in Ackr1+/+➔Ackr1−/− mice reached 
significance only for the percentage of time spent in the center and for the number of 
hypoactive events (actometer, Figure 8 D, F) as well as for average running speed (elevated 
plus maze, Figure 7A), suggesting a limited contribution of hematopoietic Ackr1. The 
Ackr1−/− ➔ Ackr1+/+ bone marrow chimeras imitate the situation in malaria-resistant 
Ackr1-negative humans (11) that selectively lack Ackr1 on red blood cells, while receptor 
expression is maintained in other tissues, e.g. vascular endothelium (41). No psychological 
or behavioral abnormalities have been described for these persons, which is consistent with 
the absence of a behavioral phenotype in our Ackr1−/− ➔ Ackr+/+ bone marrow chimeras.
Importantly, most of the behaviors we found to be abnormal in the Ackr1−/− mouse, even 
anxiety-like behavior, have also been reported to be abnormal in one or more of three well-
known mouse models of selective cerebellar degeneration: the Lurcher mouse (Lc/+), the 
Purkinje cell degeneration mouse (pcd/pcd) and the “nervous” mouse (nr/nr) (Table 2). All 
three models lose Purkinje neurons almost completely and – depending on the mutation – 
undergo degeneration of other cerebellar regions and other types of neurons like the granular 
or molecular layer (28, 30, 42, 43). Thus, it is plausible that Ackr1 deficiency in cerebellum, 
and not in other brain regions where it is expressed, accounts for most if not all of the 
behavioral phenotypes in Ackr1−/− mice. However, interestingly, the behavioral phenotypes 
in these three cerebellar degeneration models are mostly the opposite of the corresponding 
phenotypes in Ackr1−/− mice. Only rotarod performance was impaired in all four mutant 
mice (28, 44, 45). A reasonable hypothesis to explain these results is that Ackr1 functions on 
neurons, as it does on erythrocytes, as a negative regulator, so that its loss increases 
cerebellar function, leading to the opposite phenotype as in the selective cerebellar 
degeneration mutants. Mechanisms of negative regulation could include scavenging of 
chemokines that act at G protein-coupled chemokine receptors on neurons, alternative 
signaling by neuronal Ackr1 in response to cognate chemokines produced by neurons and/or 
microglial cells, even signaling or scavenging by Ackr1 after binding non-chemokine 
ligands, including known neurotransmitters. Alternatively, Ackr1 could present chemokines 
to signaling receptors on neurons. The levels of free chemokines in blood and cerebellum 
may be governed by a balance of binding to Ackr1, dissociation from Ackr1 and by the rate 
of chemokine metabolism.
Additional work will be needed to test each of these possibilities. However, there are already 
reports indicating that pieces of the model are in place and that Ackr1-binding chemokines 
directly stimulate cerebellar Purkinje neurons, which motivated our work. In particular, 
Purkinje neurons, in addition to expressing Ackr1, express the Ackr1-binding chemokine 
CCL2 and its receptor CCR2, as well as receptors for the Ackr1-binding chemokines CCL5 
and CCL11 (18, 23, 46); CCL2 has been reported to induce Ca2+ flux in isolated rat Purkinje 
neurons (18); the Ackr1-binding chemokine CXCL8 causes Ca2+ transients and enhances 
neurotransmitter release in mouse cerebellar slices (19); and CXCL2, which also binds to 
Ackr1 (20), causes ERK activation and modulates neurotransmitter release in rat cerebellum 
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(22). In addition, brain mast cells are active under basal non-inflammatory conditions (47) 
and can release chemokines, including the Ackr1 ligands CCL2 and CCL5 (48). Moreover, 
blockade of central mast cell activation has been reported to be associated with increased 
anxiety-like behavior in mice (49), indicating another link between behavior and immune 
function. Astrocytes and microglial cells also express chemokines, including Ackr1 ligands 
(50). Another level of potential complexity is added by the ability of Ackr1 to influence 
signaling of other chemokine receptors like CCR5 by forming hetero-oligomers (51). It is 
intriguing to consider that Ackr1 might also interact in a chemokine-dependent manner with 
neurotransmitter receptors on Purkinje neurons and therefore modulate “classic” 
neurotransmitter responses.
In summary, our results demonstrate that Ackr1 plays an important role in regulating the 
central nervous system at the level of motor function and behavior. As indicated by our MRI 
results, Ackr1 deficiency does not result in gross abnormalities of the cerebellum and other 
brain regions, but rather seems to affect neurotransmission and activity of Purkinje neurons. 
In addition to neuropeptides and neurotransmitters, chemokines may in fact represent a 
“third major system of communication in the brain” (52). To our knowledge, this is the most 
detailed behavioral characterization available for a chemokine receptor-deficient mouse. Our 
results provide a starting point for deeper investigation of the role of chemokines in the 
modulation of cerebellar function and – via cerebellar projections – of other brain areas.
Methods
Laboratory animals
Ackr1−/− mice generated as previously described (8) were backcrossed at least 10 
generations to C57Bl/6 mice, strain 664 (Jackson Laboratories, Woods Hole, MA) and, 
unless otherwise indicated, were bred in the same facility. Except for littermates, mice were 
housed separately by genotype, a maximum of five mice per cage; all mice were maintained 
at 22°C on a 12-h light/dark cycle (lights off at 6 pm). Mice were transferred to the behavior 
laboratory at least one week prior to the experiment, and tested between 10 am and 5 pm. 
Except for radiation chimeras, whose ages were heterogeneous, the groups were age-
matched with a maximum difference of two weeks. All experiments complied with 
guidelines set by the NIAID Animal Care and Use Committee (NIH).
Rotarod Experiments
Three to five month old mice were tested on one- or five-station rotarods (MedAssociates, 
St. Albans, VT, USA) from 12-6 pm. Each experiment involved two training sessions and 
1–2 test sessions. Training session 1 consisted of a habituation trial on a stationary rod and 
three trials at 4 rpm, each lasting 60 s, with 45 seconds rest in between. 24 h later, training 
session 2 began, consisting of 3 trials in which the rod accelerated from 4 to 16 rpm within 
100 seconds, with 100 seconds rest in between. The test session began 24 hours later, and 
consisted of three acceleration trials (4 to 40 rpm over 300 seconds) with 5–10 minutes rest 
in between. The endpoint was defined to occur when the mouse fell off the rotarod and 
disrupted an infrared beam. If animals started to cling to the rod to rotate passively, 
specifically at higher rotarod speeds, we did not intervene, but waited for the animals to fall 
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off the rod. In littermate experiments, the test session was repeated 24 h later with the same 
animals, but in reversed order to avoid circadian rhythm effects. The frequency of 180° turns 
made on the rotarod relative to vertical was calculated by dividing the mean number of turns 
by the mean trial duration for each individual animal and experimental day. All experiments 
were performed at full illumination. The rotarod was cleaned between trials.
Elevated Plus Maze Experiments
3–4 month old mice were tested once for 5 min on a plus sign-shaped maze with two open 
and two closed arms situated 60 cm above the floor and illuminated at 60–75 lux in the 
center. Each arm is 30 cm long and 5 cm wide. The mouse is placed in the center (5 × 5 cm) 
and allowed to freely explore the maze. Movements were recorded using an Ethovision 
video-tracking system (Noldus, Wageningen, Netherlands). The maze was cleaned, if 
necessary, with 70% ethanol. The experiment followed the rotarod experiment during which 
the mice got habituated to an “out of cage” experience.
Actometer Experiments
Development of the force-plate actometer has been previously described in detail (53). In 
brief, the actometer consists of a force-sensing plate (42 × 42 cm) mounted on force 
transducers in the four corners, which establish the location of the center of mass of the 
animal. The system produces a signal that depends on the weight and movements of the 
animal exploring the space. An enclosure suspended 2 mm above the surface confines the 
animal. Mice were placed in the center and allowed to freely explore the plate. 
Measurements were made for 30 min at an illumination of ~45 lux during the light phase 
between 10 am and 6 pm at a time resolution of 100 Hz and a force resolution of 0.2 gram-
force, and were also recorded using a digital camera. The actometer was cleaned between 
sessions with 70% ethanol.
Locomotor activity was determined by calculating the distance moved during a session, 
based on the smoothed force variations (moving average of 9 data points). ‘Hypoactive 
events’ were defined as movement within a radius of <15 mm for at least 5 s. The 
percentage of time spent in the center was defined as the time spent in the central square that 
occupies 6% of the force plate area.
Within run force range and gait rhythm were determined from “long runs”, defined as 
periods of lateral movements over a distance of 20 cm or more within a time frame of 2 s, 
following an almost straight line between starting and ending points. Straightness of the 
trajectory was evaluated by analysis of the obtuse angle of a triangle formed by a straight 
line connecting starting and ending point and the two segments from starting point to the 
middle and from ending point to the middle. An obtuse angle of 180° would mean a totally 
straight line. The run was included in the analysis if the obtuse angle was greater than 160°.
For the determination of wall rear number and duration, the raw data of the force variations 
were smoothed (moving average of 9 data points), transformed to percent of body weight 
and the mean (100%) was subtracted. Wall rears were defined as an off-load force between 
5% and 40%, lasting at least 0.25 s. This discriminates wall rears from jumps (maximum 
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off-load force 100%) and locomotion (off-load force between 30% and 90%, but shorter 
duration than 0.25 s).
Harmaline-induced tremor was investigated using ~5 month old Ackr1−/− and Ackr1+/+ 
littermates. First, PBS buffer was injected (5 ml/kg i.p.) followed immediately by a 30 min 
actometer session. 10–24 days later, the same animals were injected i.p. with 15 mg/kg 
harmaline (3 mg/mL in PBS) and again immediately monitored on the actometer for 30 min. 
Sessions were not performed after 5 pm to avoid any change of behavior from anticipating 
the dark phase. For the quantitation of harmaline tremor intensity and frequency, the raw 
data (expressed as percent of body weight with offset removed and after application of the 
Hanning data window) were converted to power spectra by a Fourier transformation 
(MatLab). The power spectra were calculated for each 10-s time frame of the recording 
session. Then the twelve 10-s frames with the highest peak power between 8 and 18 Hz were 
chosen for each mouse and averaged together, resulting in the maximum tremor exhibited by 
each individual mouse. This method was used to exclude “silent” periods that occur between 
bouts of harmaline tremor expression. From the resulting average power spectrum for each 
individual animal the parameters “peak power” and “frequency at peak” were calculated and 
subjected to statistical analysis.
For characterization of the mice in the bone marrow transfer experiments, experiments with 
PBS- and harmaline injection were performed essentially as described above, but 
observation time was reduced to 20 min, starting at 10 min after PBS- or harmaline 
injection. Since the maximum of the harmaline tremor is not reached before 10 min post-
injection, the shortening of the time does not affect the harmaline tremor data calculated 
from the peak tremor.
Water Maze Experiments
The water-maze consists of grey PVC and has a diameter of 100 cm and a height of 45 cm. 
The water is kept at ~22°C and is stained with non-toxic white paint to increase contrast and 
rendering it opaque. Lights were covered to eliminate reflections. The pool area was 
illuminated indirectly at 30–40 lux on the water surface. A Perspex platform (9×9 cm), is 
placed 0.5–0.8 cm below the surface, invisible to the swimming mouse, ~10 cm from the 
pool edge. Distal visual cues (wall posters ~0.50–0.75 m in size with different geometrical 
patterns) surround the pool. The experiment consists of four phases. (1) Habituation (day1): 
Mice are given three swim trials, each 60 s long, with 10–15 min rest in between. (2) 
Acquisition learning phase (7 consecutive days, 4 trials per day): Mice are released from 4 
different symmetrical positions on the pool perimeter and attempt to find the platform, 
which is kept at the same position. Each trial lasts 60 s with 10–15 min rest in between. If 
unsuccessful, the mouse is placed on the platform for 10 s to foster learning. After each trial, 
the mice are dried with a paper towel under a heat lamp. Visual orientation prior to release 
into the pool is prevented using a non-transparent box to transport mice to the water maze. 
On the day following the 7-day acquisition phase, a probe trial is performed, during which 
the platform is removed from the pool and each mouse is placed in the pool for 60 s. (3) 
Reversal learning phase: the day after the acquisition test, the platform is moved to a 
different position and kept there for the following 4 days. During this time, the mice are 
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tested according to the same protocol as described for the acquisition learning phase. Then, 
the platform is removed for a second probe trial. (4) Visual cue test: immediately after the 
reversal test, the hidden platform is raised above the water surface in the center of the pool. 
Two visual cue tests were performed to let the mice find the visible platform. Swim paths 
were recorded using an Ethovision video-tracking system (Noldus, Wageningen, 
Netherlands). For the acquisition and reversal phases the variables recorded were latency to 
reach the platform, mean swimming speed, swim path distance as well as percentage of the 
total time spent along the edge of the water maze (% thigmotaxis time). For the probe trials, 
the variables recorded were time to swim to the prior location of the hidden platform 
(latency), number of crossings (frequency) over the prior location of the hidden platform, 
time spent in the vicinity (quadrant of the circular pool) where the platform had been 
located, number of entries into the quadrant where the platform had been located, and mean 
swim speed.
Magnetic Resonance Imaging (MRI)
All studies complied with the guide for the care and use of Laboratory Animal Resources 
(1996), National Research Council, and approved by the National Institute of Neurologic 
Diseases and Stroke (NIH) Animal Care and Use Committee. Mice were anesthetized (1.5% 
isofluorane), and body core temperature was maintained and monitored at 37°C with a 
heated circulating water pad. A pressure transducer was positioned to monitor respiration. 
Mice were then placed in a stereotaxic holder and mounted in a 72 mm volume (transmit)/ 
25 mm surface (receive) radio frequency coil ensemble for MRI. The MRI experiments were 
performed on a horizontal bore 7 Tesla scanner operating on a Bruker Avance platform 
(Bruker Biospin Inc. Bellerica, MA). Three mutually perpendicular scout images were 
acquired through the brain to localize the brain. Subsequently, 15 T2 weighted axial slices (1 
mm thick) encompassing the entire brain (Field-of-view [FOV] = 19.2 × 19.2 mm, in-plane 
resolution of 75 mm, echo time [TE] = 48 ms, repetition time [TR] = 3000 ms, echo train 
length = 8 and number of averages [NA] = 20, total imaging time 32 minutes) were acquired 
using a spin-echo pulse sequence to delineate anatomical details. For data analysis, T2 
weighted images were displayed slice by slice and regions of interests were drawn to 
calculate the area of the brain using Image J.
Generation of Bone Marrow Chimeras
Recipient mice were γ-irradiated with 900 Rad in the morning and were reconstituted with 5 
× 106 donor bone marrow cells in 200 µl buffer (isolated during the five hours after 
irradiation) 6–8h after irradiation via tail vein injection. Recipients then received 
trimethoprim-sulfamethoxazole in autoclaved water for 4 weeks. Recipient and donor mice 
were 2–4 months old at the time of bone marrow transfer. Nineteen males (5 Ackr1+/+ ➔ 
Ackr1+/+, 4 Ackr1+/+ ➔ Ackr1−/−, 5 Ackr1−/− ➔ Ackr1+/+, 5 Ackr1−/− ➔ Ackr1−/−) and 21 
females (5 Ackr1+/+ ➔ Ackr1+/+, 6 Ackr1+/+ ➔ Ackr1−/−, 5 Ackr1−/−➔ Ackr1+/+, 5 
Ackr1−/−➔Ackr1−/−) were used. Blood genotyping was performed at ~6 weeks after bone 
marrow reconstitution to assess the extent of engraftment. Rotarod and elevated plus maze 
experiments with bone marrow chimeras were performed ~8 weeks after reconstitution. 
Actometer experiments were performed at ~9 weeks (PBS control experiment) or ~13 weeks 
(harmaline experiment) after reconstitution.
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Ear punches were incubated for 2 h at 55°C in 50 µl lysis buffer (100 mM Tris-HCl [pH 
8.0], 100 mM NaCl, 10 mM EDTA [pH 8.0], 0.2 % SDS and 0.8 mg/ml proteinase K). 
Samples were vortexed, diluted with 450 µL of DEPC-treated water, then centrifuged for 6 
min at 7500 rpm.
Genotyping was performed with a three primer system:1) SCP440 (5’-
GTCTAGCCCTGCACATACC-3’), 2) DARCneo (5’-TATGGCGCGCCATCGATCTC-3’) 
and 3) DuffyCommon (5’-CCAGTAGCCCAGGTTGCATA-3’). 2 µl of ear punch extract 
were added to 23 µl of Platinum PCR Supermix™ (Life Technologies, Carlsbad, CA) 
containing 200–500 nM primers and amplified by PCR as follows: 3 min at 94°C, followed 
by 34 cycles of 30 s at 94°C, 30 s at 60°C, and 35 s at 72°C, followed by 7 min at 72 °C. 
Wild type and gene-targeted amplicons were 452 and 300 bp, respectively.Genotyping of 
chimeras was performed from blood drawn ~6 weeks after BMT. DNA was purified from 
100 µl of blood (diluted with 100 µl PBS buffer) using the QiaAMP DNA blood mini kit™ 
(Quiagen, Hilden, Germany). Percentage of engraftment was determined by comparison 
with calibration samples generated from mixtures of wild-type and Ackr1−/− blood 
containing 0, 20, 40, 60, 80 and 100 % wild-type blood.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Ackr1 deficiency impairs balance on a rotating rod (rotarod). (A, B) Male non-littermate 
Ackr1+/+ and Ackr1−/− mice. (A) Rotarod performance in three consecutive trials performed 
on the same day. (B) Rotarod performance of individual mice, average of all three trials per 
mouse. (C, D) Littermate Ackr1+/+Ackr1+/− and Ackr1−/− mice (data for male and female 
mice merged). (C) Rotarod performance of the individual mice, average of all three trials per 
mouse and day. (D) Rotarod performance in six individual trials performed on two 
consecutive experimental days (three trials per day). Data shown are means ± SEM; the 
number of animals is given in the figures. Ackr1−/− mice and Ackr1+/− animals were 
compared with Ackr1+/+ controls by t-test (A, B) or 1-way ANOVA and Newman-Keuls 
post-test (C). In (D), all three groups of mice were compared for each trial by 1-way 
ANOVA and Newman-Keuls post-test with *: comparison Ackr1+/+ to Ackr1−/− and +: 
comparison Ackr1+/+ to Ackr1+/−. One symbol: p<0.05; two symbols: p<0.005; three 
symbols: p<0.001.
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Ackr1 deficiency impairs locomotion and promotes anxiety-like behavior on the elevated 
plus maze. (A) Elevated plus maze experimental setup. The red lines indicate the threshold 
that defines “open arm end”. (B) Total number of arm entries. (C) Average running speed in 
cm/s. (D) Duration of time spent in the center square of the elevated plus maze. (E) 
Percentage of open arm entries, related to total number of arm entries. (F) Time spent in 
open arm end (open squares: two outliers that were excluded from analysis). Data shown are 
means ± SEM; the number of animals is given in the figures. Ackr1−/− mice and 
heterozygous animals were compared with C57Bl/6 controls by 1-way ANOVA and 
Newman-Keuls post-test; * p<0.05; ** p<0.005; *** p<0.001.
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Ackr1 deficiency impairs spontaneous locomotion but induces spontaneous anxiety like-
behavior and worsens harmaline-induced cerebellar tremor. All data were obtained during 
30 minute sessions on a force plate actometer after injection of either PBS (A–F) or 
harmaline (G, H). (A) Range of force variations produced during long run sequences; (B) 
Gait rhythm during long runs; (C) Duration of wall rears; (D) Percentage of time spent in the 
center of the force plate; (E) Locomotor activity (distance moved in 3 min time frames); (F) 
Number of hypoactive events (Time periods >5 s with the animal moving in a radius of < 15 
mm); (G) Intensity of harmaline-induced tremor; (H) Frequency of Harmaline-induced 
tremor. Data shown are means ± SEM. (A, B, C, D, F, G, H) Comparison of Ackr1+/− and 
Ackr1−/− mice with Ackr1+/+ controls, 1-way ANOVA with Newman-Keuls post-test; * 
p<0.05; ** p<0.005; *** p<0.001; (E) Comparison of the curves with 2-way ANOVA (p = 
0.002 for Ackr1+/+ vs. Ackr1+/− and p = 0.005 for comparison Ackr1+/+ vs. Ackr1−/−). SEM 
in (E) is < 6% of the mean for each point.
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Characterization of spatial learning of Ackr1+/+ and Ackr1−/− mice in the Morris water maze. 
(A) Latency to find the platform; (B) swimming speed; (C) swimming distance covered until 
the platform is found and (D) thigmotaxis time (time spent close to the edge of the water 
maze). Curves were compared by 2-way ANOVA with separate analyses for acquisition- 
and reversal learning phase. Summary data for all animals tested are presented as the mean 
+/− SEM. P-values are given in the graphs.
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Determination of bone marrow engraftment in radiation chimeras. Blood DNA was 
amplified by PCR, and amplicon size was determined by agarose gel electrophoresis. 
Ackr1wt and Ackr1ko amplicon positions are identified by arrows at the left side of the figure.
Each group of samples represents chimeric mice of the same composition, which is 
indicated at the top of the panel coded as donor genotype ➔ recipient genotype. Left and 
right part of the figure each show an individual gel. Dashed lines separate groups of samples 
on a contiguous part of the gel, while straight lines indicate disconnected parts of the same 
gel. The numbers above the lanes in each panel represent chimerism in individual mouse 
replicates for each condition.
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Rotarod performance of radiation bone marrow chimeras (male and female mice). Mice 
were tested on two consecutive days with three trials perday per animal. The groups are 
shown below the x-axis (donor ➔ recipient). Each symbol represents a single mouse. Bars 
represent means ± SEM of the average times spent on the rotarod during three independent 
trials for each mouse on each day; the same mice were tested on day 1 and day 2; n=10 mice 
for each condition. Groups were compared by 1-way ANOVA with Newman-Keuls post 
test; * indicates significance in comparison to the Ackr1+/+➔Ackr1+/+ group; + indicates a 
significant difference to Ackr1−/−➔Ackr1−/−; one symbol: p<0.05; two symbols: p<0.005; 
three symbols: p<0.001.
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Behavior of irradiation bone marrow chimeras on the elevated plus maze. (A) Average 
running speed, (B) total number of arm entries, (C) duration in center and (D) percentage of 
open arm entries. The groups are shown below the x-axis (donor ➔ recipient). Data shown 
are means ± SEM; each symbol represents a single mouse. Groups were compared by 1-way 
ANOVA with Newman-Keuls post test; * indicates significance in comparison to the 
Ackr1+/+➔Ackr1+/+ group; + indicates a significant difference compared to 
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Ackr1−/−➔Ackr1−/−; one symbol: p<0.05; two symbols: p<0.005; three symbols: p<0.001; n 
= 9–10 mice for each condition.
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Spontaneous behavior of radiation bone marrow chimeras on the force plate actometer. (A–
F) 20 min sessions, starting 10 min after PBS injection; (G, H) 20 min sessions, starting 10 
min after harmaline injection. (A) Range of force variations produced during long running 
sequences; (B) Gait rhythm during long runs; (C) Duration of wall rears; (D) Percentage of 
time spent in the center of the force plate; (E) Locomotor activity (distance moved in 2 min 
time frames); (F) Number of hypoactive events (Time periods >5 s with the animal moving 
in a radius of < 15 mm); (G) Intensity of harmaline-induced tremor; (H) Frequency of 
harmaline-induced tremor. Data shown are means ± SEM; n=10 mice for each condition. (A, 
B, C, D, F, G, H) Comparison of the groups by 1-way ANOVA with Newman-Keuls post 
test; * indicates significance in comparison to the Ackr1+/+ ➔ Ackr1+/+; + indicates a 
significant difference to Ackr1−/− ➔ Ackr1−/−; one symbol: p<0.05; two symbols: p<0.005; 
three symbols: p<0.001; (E) Comparison of the curves with 2-way ANOVA (significant 
differences: p = 0.011 for Ackr1+/+➔Ackr1+/+ vs. Ackr1−/−➔Ackr1−/− and p = 0.030 for 
Ackr1−/−➔Ackr1−/−vs. Ackr1−/−➔Ackr1+/+). SEM in (E) is < 5% of the mean for each point.
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p < 0.05, compared to Ackr1+/+ (Mann-Whitney U test)
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